Inflammation and Daily Life Study

Summary

Inflammation and Daily Life Study is a clinical trial^[1].

Key Facts

• Inflammation and Daily Life Study is in the country of United States^[2].
• Inflammation and Daily Life Study's instance of is recorded as clinical trial^[3].
• Inflammation and Daily Life Study's start time is recorded as +2019-01-31T00:00:00Z^[4].
• Inflammation and Daily Life Study's end time is recorded as +2019-12-31T00:00:00Z^[5].
• Inflammation and Daily Life Study's sponsor is recorded as University of California, Los Angeles^[6].
• Inflammation and Daily Life Study's main subject is recorded as inflammation^[7].
• Inflammation and Daily Life Study's number of participants is recorded as {'unit': '1', 'amount': '+100'}^[8].
• Inflammation and Daily Life Study's title is recorded as Inflammation and Daily Life Study^[9].
• Inflammation and Daily Life Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[10].
• Inflammation and Daily Life Study's ClinicalTrials.gov ID is recorded as NCT03771612^[11].
• Inflammation and Daily Life Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}^[12].
• Inflammation and Daily Life Study's research intervention is recorded as naproxen^[13].
• Inflammation and Daily Life Study's clinical trial phase is recorded as phase I clinical trial^[14].
• Inflammation and Daily Life Study's research subject recruitment status is recorded as not yet recruiting^[15].
• Inflammation and Daily Life Study's study type is recorded as interventional study^[16].